Rachel Chan

Partner
Norton Rose Fulbright Hong Kong
rachel.chan@nortonrosefulbright.com
Rachel
Chan
Rachel Chan
Hong Kong SAR
38/F Jardine House
1 Connaught Place
Central
Hong Kong SAR
+852 34052322

Rachel Chan is a corporate lawyer based in Hong Kong. She advises on M&As, takeovers, privatisation, off-market share buybacks and other equity capital market transactions.

Representative experience

  • Cathay Pacific Airways Limited (293.HK): Off-market share buyback by Cathay Pacific from Qatar Airways. Advised HSBC, the financial adviser to Qatar Airways.
  • L’Occitane International S.A (973.HK): Advised management shareholder of L’Occitane Group S.A in relation to the skin care company’s €6bn take-private offer of L’Occitane International S.A.
  • Vinda International (3331.HK prior to delisting): Privatisation by voluntary general offer by Isola Castle Ltd.
  • CTF Servies Limited (formerly NWS Holdings) (659.HK): Voluntary general offers by Chow Tai Fook Enterprises for shares in NWS Holdings Limited. Advised HSBC, BOCI and ING, the joint financial advisers to Chow Tai Fook Enterprises.
  • Kangda International (6136.HK): mandatory cash offers by China Water Affairs Group Limited (855.HK) and its chairman as joint offerors, to acquire all shares and cancel all outstanding options of Kangda International.
  • Beijing Capital Grand (1329.HK prior to delisting): Privatisation by scheme of arrangement by its controlling shareholder.
  • China Mengniu Dairy (2319.HK): Privatisation of Yashili International (1230.HK) by scheme of arrangement. Advised HSBC, the financial adviser to China Mengniu Dairy
  • Beijing Capital Land (2868.HK prior to delisting): Privatisation by merger by absorption by Capital Group.
  • China Taiping Insurance (0966.HK) and Taiping Reinsurance: Ageas' subscription of equity interests in Taiping Reinsurance and Taiping Pension Co., Ltd.
  • China Resources Power (836.HK) and China Resources consortium: Acquisition by way of a competitive auction of a 30% stake in Dudgeon Offshore Wind Farm in the United Kingdom.
  • JBM (Healthcare) (2161.HK): Spin-off listing and public offer.

Awards and recognitions

“A key name for investment banks and issuers seeking advice on auction sales, public takeovers, and cross-border M&A.”
Legal 500 Hong Kong Corporate and M&A 2025

Admissions

  • Solicitor, qualified in Hong Kong

Languages

  • Cantonese
  • English
  • Mandarin Chinese
Bio